Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Carbamazepine may cause reversible nail detachment.

Neurosteroids from glia cells help control seizure development in epilepsy.

Some psychiatric medications can cause reversible hair loss.

Long-term use of seizure medications can disrupt calcium metabolism, but this can be treated with vitamin D or UV light and does not affect seizure control.

Haloperidol decanoate can cause alopecia areata.

Choosing the right estroprogestin is crucial for effectively managing PCOS symptoms.

Squaric acid dibutylester effectively treats alopecia areata.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Valproic acid can cause a skin condition called leukocytoclastic vasculitis, which usually gets better after stopping the drug.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Valproic acid can rarely cause fluid buildup around the lungs and heart.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Two elderly men developed scalp inflammation after using a gel for skin lesions, which healed with treatment except for some permanent hair loss.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

The document does not give specific results for hair loss treatment effectiveness.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

A woman's hair grew back after she stopped taking the Parkinson's disease medication pramipexole.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Some drugs for inflammation may cause psoriasis-like hair loss.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.